Earnings History Data for CorMedix Inc. (CRMD) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

CorMedix Inc.

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead product Defencath (TM), a novel, antibacterial and antifungal solution designed to prevent costly and life-threatening bloodstream infections associated with the use of central venous catheters in patients undergoing chronic hemodialysis. Defencath has been designated by FDA as Fast Track and as a Qualified Infectious Disease Product, which provides an additional five years of marketing exclusivity, which will be added to the five years granted to a New Chemical Entity upon approval of the NDA. CorMedix also intends to develop Defencath as a catheter lock solution for use in oncology and total parenteral nutrition patients. It is leveraging its taurolidine technology to develop a pipeline of antimicrobial medical devices, with programs in surgical sutures and meshes, and topical hydrog

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
30-10-2024	PM		CRMD	CorMedix Inc.	759.14	-0.05	-0.10	-0.17	CorMedix GAAP EPS of -$0.05 beats by $0.05, revenue of $11.46M beats by $0.62M [10/30/2024 7:37 AM]	10.06	-2.91 (-22.40%)	11.51	-1.46 (-11.26%)	2.57 - 13.85	4,083,302	1,500,000	45,279
CorMedix Q3 2024 Earnings Preview [10/29/2024 3:48 PM] CorMedix GAAP EPS of -$0.05 beats by $0.05, revenue of $11.46M beats by $0.62M [10/30/2024 7:37 AM] CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update [2024-10-30 07:30AM] Cormedix Inc (CRMD) Q3 2024 Earnings Report Preview: What To Look For [Oct-29-24 09:13AM]
14-08-2024	PM		CRMD	CorMedix Inc.	209.94	-0.25	-0.26	-0.25	CorMedix GAAP EPS of -$0.25 in-line, revenue of $0.81M misses by $0.86M [8/14/2024 7:34 AM]	4.91	1.13 (29.76%)	4.14	0.36 (9.52%)	2.57 - 7.00	2,731,623	520,000	25,966
CorMedix Q2 2024 Earnings Preview [8/13/2024 12:19 PM] CorMedix GAAP EPS of -$0.25 in-line, revenue of $0.81M misses by $0.86M [8/14/2024 7:34 AM]
09-05-2024	PM		CRMD	CorMedix Inc.	321.09	-0.25	-0.27	-0.24	CorMedix GAAP EPS of -$0.25 [5/9/2024 7:54 AM]	5.45	-0.26 (-4.51%)	5.77	0.07 (1.14%)	2.57 - 7.00	802,109	640,000	2,805
CorMedix GAAP EPS of -$0.25 [5/9/2024 7:54 AM]
12-03-2024	PM		CRMD	CorMedix Inc.	201.71	-0.26	-0.21	-0.20	CorMedix GAAP EPS of -$0.26 misses by $0.06 [3/12/2024 7:31 AM]	3.42	-0.10 (-2.70%)	3.37	-0.15 (-4.26%)	2.57 - 6.09	1,172,398	350,000	6,743
CorMedix Q4 2023 Earnings Preview [3/11/2024 12:08 PM] CorMedix GAAP EPS of -$0.26 misses by $0.06 [3/12/2024 7:31 AM]
14-11-2023	AH		CRMD	CorMedix Inc.	176.47	-0.17	-0.21	-0.17	CorMedix GAAP EPS of -$0.17 beats by $0.04 [11/14/2023 4:10 PM]	3.35	0.22 (6.96%)	3.69	0.56 (17.89%)	2.57 - 6.09	13,013,495	770,000	510,007
CorMedix GAAP EPS of -$0.17 beats by $0.04 [11/14/2023 4:10 PM] CorMedix rallies on FDA nod for anti-infective agent DefenCath [11/15/2023 10:33 AM]
08-08-2023	PM		CRMD	CorMedix Inc.	193.31	-0.25	-0.22	-0.19	CorMedix GAAP EPS of -$0.25 misses by $0.01 [8/8/2023 7:33 AM]	4.42	0.32 (7.81%)	4.10	0.0 (0.00%)	2.71 - 8.02	614,193	600,000	202
CorMedix GAAP EPS of -$0.25 misses by $0.01 [8/8/2023 7:33 AM]
15-05-2023	AH	After the close (May 15)	CRMD	CorMedix Inc.	236.29	-0.24	-0.20	-0.18	CorMedix GAAP EPS of -$0.24 misses by $0.04 [5/15/2023 4:12 PM]	4.49	-0.66 (-12.82%)	5.20	0.05 (0.89%)	2.64 - 8.02	851,019	260,000	11,953
CorMedix GAAP EPS of -$0.24 misses by $0.04 [5/15/2023 4:12 PM] CorMedix resubmits marketing application for lead candidate DefenCath [5/16/2023 10:13 AM]
30-03-2023	PM	7:30 AM ET (Mar 30)	CRMD	CorMedix Inc.	161.00	-0.20	-0.19	-0.20	CorMedix GAAP EPS of -$0.20 misses by $0.01, revenue of $0.03M beats by $0.03M [3/30/2023 7:32 AM]	4.14	0.48 (13.11%)	3.85	0.19 (5.19%)	2.64 - 8.02	524,369	170,000	31,280
CorMedix GAAP EPS of -$0.20 misses by $0.01, revenue of $0.03M beats by $0.03M [3/30/2023 7:32 AM]
10-11-2022	PM	7:30 AM ET (Nov 10)	CRMD	CorMedix Inc.	123.62	-0.17	-0.23	-0.22	CorMedix GAAP EPS of -$0.17 beats by $0.06, revenue of $6.82M [11/10/2022 7:36 AM]	3.09	0.26 (9.19%)	3.07	0.24 (8.48%)	2.64 - 8.02	326,124	150,000	21,079
CorMedix GAAP EPS of -$0.17 beats by $0.06, revenue of $6.82M [11/10/2022 7:36 AM] CorMedix Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update [Nov-10-22 07:30AM]
11-08-2022	PM	0:00 AM ET (Aug 11)	CRMD	CorMedix Inc.	212.05	-0.19	-0.20	-0.12	CorMedix GAAP EPS of -$0.19 beats by $0.02, revenue of $0.02M [8/11/2022 8:02 AM]	3.72	0.34 (10.09%)	3.26	-0.12 (-3.55%)	2.65 - 8.03	1,394,093	1,140,000	65,116
CorMedix GAAP EPS of -$0.19 beats by $0.02, revenue of $0.02M [8/11/2022 8:02 AM] CorMedix Inc. Reports Second Quarter and Six Month 2022 Financial Results and Provides Business Update [Aug-11-22 07:30AM]
12-05-2022	AH	4:00 PM ET (May 12)	CRMD	CorMedix Inc.	130.90	-0.18	-0.23	-0.20	CorMedix GAAP EPS of -$0.18 beats by $0.04, revenue of $0.01M misses by $0.01M [5/12/2022 4:05 PM]	3.27	0.29 (9.73%)	3.20	0.22 (7.38%)	2.87 - 8.38	257,292	310,000	3,705
CorMedix hires new CEO, makes other executive changes; new operational focus [5/12/2022 9:28 AM] CorMedix GAAP EPS of -$0.18 beats by $0.04, revenue of $0.01M misses by $0.01M [5/12/2022 4:05 PM] CorMedix Inc. Announces Leadership Updates and Operational Changes [May-12-22 08:30AM] CorMedix Inc. Reports First Quarter 2022 Financial Results and Provides Business Update [May-12-22 04:01PM]
29-03-2022	AH	4:05 PM ET (Mar 29)	CRMD	CorMedix Inc.	230.80	-0.20	-0.22	-0.19	CorMedix GAAP EPS of -$0.20 beats by $0.03, revenue of $0.06M beats by $0.05M [3/29/2022 4:06 PM]	5.83	0.29 (5.23%)	5.80	0.26 (4.69%)	3.65 - 10.40	847,902	460,000	2,336
CorMedix GAAP EPS of -$0.20 beats by $0.03, revenue of $0.06M beats by $0.05M [3/29/2022 4:06 PM] CorMedix stock soars 13% following Q4 results [3/30/2022 11:58 AM] CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath [Mar-28-22 08:30AM] CorMedix Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update [Mar-29-22 04:01PM]
09-11-2021	AH	4:00 PM ET (Nov 9)	CRMD	CorMedix Inc.	200.33	-0.22	-0.18	-0.22	CorMedix EPS misses by $0.04, beats on revenue [11/9/2021 4:13 PM]	5.29	0.06 (1.15%)	5.05	-0.18 (-3.44%)	4.36 - 18.80	316,152	290,000	5,518
CorMedix EPS misses by $0.04, beats on revenue [11/9/2021 4:13 PM] CorMedix Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update [Nov-09-21 04:05PM]
12-08-2021	AH	4:00 PM ET (Aug 12)	CRMD	CorMedix Inc.	228.70	-0.12	-0.18	-0.14	CorMedix EPS beats by $0.06, misses on revenue [8/12/2021 4:10 PM]	6.35	0.40 (6.72%)	6.01	0.06 (1.01%)	3.86 - 18.80	394,314	210,000	953
CorMedix EPS beats by $0.06, misses on revenue [8/12/2021 4:10 PM] CLASS ACTION UPDATE for JRVR, CRMD and ATVI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Aug-11-21 08:25PM] Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tarena, Orphazyme, DiDi, and CorMedix and Encourages Investors to Contact the Firm [Aug-11-21 08:00PM] SHAREHOLDER ALERT: JRVR COIN CRMD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines [Aug-11-21 07:15PM] ROSEN, LEADING INVESTOR COUNSEL, Encourages CorMedix Inc. Investors with Losses Over $100K to Secure Counsel Before Important September 20 Deadline in Securities Class Action CRMD [Aug-11-21 07:00PM] ALERT: Robbins Geller Rudman & Dowd LLP Announces That Investors with Substantial Losses Have Opportunity to Lead the CorMedix Inc. Class Action Lawsuit - CRMD [Aug-11-21 06:45PM] SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CorMedix Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 20, 2021 - CRMD [Aug-11-21 02:08PM] SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CorMedix Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Aug-11-21 12:40PM] Lawsuits Filed Against OCGN, CRMD and ARDX - Jakubowitz Law Pursues Shareholders Claims [Aug-11-21 12:10PM] The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of CorMedix Inc. (CRMD) Investors [Aug-11-21 11:40AM] The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OCGN, CRMD and AHCO [Aug-11-21 11:00AM] INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CorMedix Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Aug-11-21 10:22AM] SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CorMedix Inc. of Class Action Lawsuit and Upcoming Deadline - CRMD [Aug-11-21 09:03PM] CLASS ACTION UPDATE for SRAC, CRMD and OTLY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Aug-12-21 05:40AM] Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CorMedix Inc. (CRMD) [Aug-12-21 11:00AM] DEADLINE ALERT for RCAR, BLCT, COIN, and CRMD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders [Aug-12-21 11:35AM] The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CRMD, CXO and ATVI [Aug-12-21 11:45AM] SHAREHOLDER ALERT: Robbins LLP Reminds Investors that CorMedix Inc. (CRMD) is Being Sued for Misleading Shareholders [Aug-12-21 12:25PM] CRMD ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 20, 2021 in the Class Action Filed on Behalf of CorMedix Inc. Limited Shareholders [Aug-12-21 01:56PM] CorMedix Inc. Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update [Aug-12-21 04:01PM] SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CorMedix Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Aug-13-21 11:16AM] The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HMPT, CRMD and ITRM [Aug-13-21 11:45AM] CLASS ACTION UPDATE for HMPT, CRMD and CXO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Aug-13-21 04:35PM] Rosen, A Top Ranked Law Firm, Encourages CorMedix Inc. Investors with Losses to Secure Counsel Before Important September 20 Deadline in Securities Class Action - CRMD [Aug-13-21 03:58PM]
13-05-2021	AH	4:05 PM ET (May 13)	CRMD	CorMedix Inc.	323.59	-0.20	-0.18	-0.21	CorMedix EPS misses by $0.02, beats on revenue [5/13/2021 4:23 PM]	6.01	-1.55 (-20.50%)	5.57	-1.99 (-26.32%)	3.64 - 18.80	2,881,406	310,000	171,968
CorMedix names Thomas Nusbickel chief commercial officer [5/13/2021 8:45 AM] CorMedix EPS misses by $0.02, beats on revenue [5/13/2021 4:23 PM] CorMedix slumps 20% despite a surge in Q1 revenue [5/14/2021 3:34 PM] CorMedix Inc. Announces Appointment of Chief Commercial Officer [May-13-21 08:30AM] CorMedix, Inc. to Host Earnings Call [May-13-21 02:30PM] CorMedix Inc. Reports First Quarter 2021 Financial Results and Provides Business Update [May-13-21 04:01PM]
30-03-2021	AH	4:05 PM ET (Mar 30)	CRMD	CorMedix Inc.	274.73	-0.19	-0.23	-0.21	CorMedix EPS beats by $0.03, beats on revenue [3/30/2021 4:07 PM]	10.00	1.01 (11.23%)	8.70	-0.29 (-3.23%)	3.00 - 18.80	923,816	590,000	2,685
CorMedix EPS beats by $0.03, beats on revenue [3/30/2021 4:07 PM] CorMedix Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update [Mar-30-21 04:05PM]
05-11-2020	AH	4:05 PM ET (Nov 5)	CRMD	CorMedix Inc.	169.00	-0.22	-0.26	-0.22	CorMedix EPS beats by $0.04, beats on revenue [11/5/2020 5:55 PM]	5.28	-0.10 (-1.86%)	5.04	-0.34 (-6.32%)	2.16 - 7.97	182,791	209,640	13,381

10-08-2020	AH	4:10 PM ET (Aug 10)	CRMD	CorMedix Inc.	114.44	-0.14	-0.24	-0.24	CorMedix EPS in-line, misses on revenue [8/10/2020 4:28 PM]	4.19	-0.06 (-1.41%)	4.20	-0.05 (-1.18%)	2.16 - 8.64	253,833	749,293	1,662